| 产品描述: | SETD抑制剂;SETD Inhibitors;;InformationUNC0379 UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransferase SETD8 with IC50 of 7.9 μM, high selectivity over 15 other methyltransferases.TargetsSETD8 (Cell-free assay) 7.3 μMIn vitroUNC0379 is competitive with the peptide substrate and noncompetitive with the cofactor SAM. |
| 体内研究: |
UNC0379(气管内给药,1 mg/kg/天,于第7、8、9天给药)可改善博来霉素(BLM)诱导的肺纤维化小鼠模型的肺部纤维化程度。 |
| 参考文献: |
1. Ma A, et al. Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8. J Med Chem. 2014 Aug 14;57(15):6822-33. 2. Miku Wada, et al. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer. Biomolecules. 2020 Dec 16;10(12):1686. 3. Keita Ugai, et al. Inhibition of the SET8 Pathway Ameliorates Lung Fibrosis Even Through Fibroblast Dedifferentiation. Front Mol Biosci. 2020 Aug 5;7:192. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.418 ml |
12.09 ml |
24.18 ml |
| 5 mM |
0.484 ml |
2.418 ml |
4.836 ml |
| 10 mM |
0.242 ml |
1.209 ml |
2.418 ml |
| 50 mM |
0.048 ml |
0.242 ml |
0.484 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |